Novartis CEO Joseph Jimenez spoke to WSJ's Deborah Ball about the impact that a Trump presidency could have on the pharmaceutical industry.
Novartis CEO Joseph Jimenez spoke to WSJ's Deborah Ball about the impact that a Trump presidency could have on the pharmaceutical industry.